STOCK TITAN

CC Form 4: Executive tax-withholding of 649 shares, no sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Chemours Company (CC) Form 4 filing – 8/1/2025

President, Thermal & Specialized Solutions, Joseph T. Martinko reported an automatic share disposition coded “F,” indicating 649 common shares were withheld by the company at $11.50 to cover taxes triggered by the vesting of restricted stock units (RSUs) and related dividend-equivalent units. No shares were sold on the open market; therefore, the transaction is exempt under Rule 16b-3.

  • Post-transaction beneficial ownership: 30,936.6241 shares (direct)
  • Insider role: Executive officer – President, Thermal & Specialized Solutions
  • Purpose: Tax withholding; routine administrative event

Given the small share count (<0.1% of total ownership) and non-cash nature, the filing is considered operationally routine with minimal investment impact.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine tax-withholding; no open-market sale, immaterial to share supply or sentiment.

The Form 4 shows an executive’s RSU vesting event where 649 shares were surrendered to satisfy withholding. Such F-code transactions neither affect cash flow nor signal a change in insider conviction. Martinko retains ~31k shares, maintaining equity alignment. Volume is negligible versus Chemours’ average daily volume (~1.4 M). As no open-market sale occurred, dilution or market pressure is nonexistent; therefore, I classify the disclosure as neutral.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Martinko Joseph T.

(Last) (First) (Middle)
C/O THE CHEMOURS COMPANY
1007 MARKET STREET

(Street)
WILMINGTON DE 19801

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
See Remarks
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/01/2025 F(1) 649 D $11.5 30,936.6241(2) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares automatically withheld to satisfy tax obligations on vesting restricted stock units and dividend equivalent units. Transactions are exempt from Section 16(b) pursuant to Rule 16b-3. No shares were sold.
2. Includes directly owned shares, restricted stock units and dividend equivalent units.
Remarks:
President, Thermal & Specialized Solutions; Power of Attorney attached as Exhibit 24.
/s/ Eric Stein, Attorney-in-Fact 08/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Chemours Co

NYSE:CC

View CC Stock Overview

CC Rankings

CC Latest News

CC Latest SEC Filings

CC Stock Data

2.66B
149.68M
Specialty Chemicals
Chemicals & Allied Products
Link
United States
WILMINGTON